Alexion Pharmaceuticals ( ALXN )
How has the company changed?
Name Type Last Updated
How Did Alexion Pharmaceuticals [ALXN] Fare in 2018 and What Can We Expect In 2019? Annual 2019-10-05
How Did Alexion Pharmaceuticals [ALXN] Fare in 2018 and What Can We Expect In 2019? Annual 2019-06-02


Name Type Last Updated
Cost Of Sales Annual 2019-01-23
Net Product Sales Annual 2019-01-23
Other Income And Expense: Foreign Currency Gain Annual 2019-01-23
Other Revenue Annual 2019-01-23
Revenues Annual 2019-01-23


How does it make money?
Name Type Last Updated
What Are The Key Drivers Of Alexion Pharmaceuticals's Expenses? Annual 2019-10-04


Income Statement Data: Historicals & Forecasts
Name Type Last Updated
Other Revenue: Total Revenues 2014-2020 Annual 2019-05-26
Net Product Sales: Total Revenues 2014-2020 Annual 2019-05-26
Total Revenues 2014-2020 Annual 2019-05-26
Operating Expenses: Acquired In-process Research And Development 2016-2020 Annual 2019-05-26
Cost Of Sales 2014-2020 Annual 2019-05-26
Cost Of Sales: Cost Of Goods Sold Gain Related To Intellectual Property Settlement 2014-2020 Annual 2019-05-26
Cost Of Sales: Total Cost Of Sales 2014-2020 Annual 2019-05-26
Operating Expenses: Impairment Of Intangible Assets 2014-2020 Annual 2019-05-26
Operating Expenses: Restructuring Expenses 2014-2020 Annual 2019-05-26
Operating Expenses: Research And Development 2014-2020 Annual 2019-05-26
Operating Income 2014-2020 Annual 2019-05-26
Other Income And Expense: Interest Expense 2014-2020 Annual 2019-05-26
Other Income And Expense: Investment Income 2014-2020 Annual 2019-05-26
Other Income And Expense: Other Income And 2014-2020 Annual 2019-05-26
Net Income Attributable To Parent 2014-2020 Annual 2019-05-26
Net Income Growth 2015-2020 Annual 2019-05-26
Net Income Margin 2014-2020 Annual 2019-05-26
Operating Expenses: Selling General And Administrative 2014-2020 Annual 2019-05-26
Earnings Before Taxes 2014-2020 Annual 2019-05-26
Income Tax Provision 2014-2020 Annual 2019-05-26
Change in EPS 2015-2020 Annual 2019-05-26
Earnings Per Share: Basic 2014-2020 Annual 2019-05-26
Shares Used In Computing Earnings Per Common Share: Weighted Average Number Of Shares Outstanding Basic 2014-2020 Annual 2019-05-26
Earnings Per Share: Diluted 2014-2020 Annual 2019-05-26
Shares Used In Computing Earnings Per Common Share: Weighted Average Number Of Shares Outstanding Diluted 2014-2020 Annual 2019-05-26
Operating Expenses: Acquisition-related Costs 2014-2020 Annual 2019-05-26
EBIT % of Sales 2014-2020 Annual 2019-05-26
Operating Expenses 2014-2020 Annual 2019-05-26
R&D % of Sales 2014-2020 Annual 2019-05-26
SG&A % of Sales 2014-2020 Annual 2019-05-26
EBT Growth 2015-2020 Annual 2019-05-26
Revenue Growth 2015-2020 Annual 2019-05-26
Tax Rate 2014-2020 Annual 2019-05-26
Change in EBT 2015-2020 Annual 2019-05-26
Change in Total Expense 2015-2020 Annual 2019-05-26
Operating Expenses: Amortization Of Purchased Intangible Assets 2014-2020 Annual 2019-05-26
Operating Expenses: Business Combination Acquisition Related Costs 2014-2020 Annual 2019-05-26
Operating Expenses: Change In Fair Value Of Contingent Consideration 2014-2020 Annual 2019-05-26
Total Expense 2014-2020 Annual 2019-05-26